Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects

Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects

Early diagnosis and treatment of rheumatoid arthritis (RA) are of critical importance to halt the progression of the disease. Optimal use of advanced imaging techniques or biomarkers may facilitate early diagnosis of RA. Even though many disease-modifying anti-rheumatic drugs (DMARDs) are available...

Full description

Saved in:
Bibliographic Details
Main Authors: Bruno Fautrel, Josef S Smolen, Fabrizio Benedetti, Roberto Caporali, Thomas Doerner, Burkhard Pieper, Minjun Jang
Format: Article
Language:English
Published: BMJ Publishing Group 2021-06-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/7/2/e001637.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items